Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Corbus Pharmaceuticals Holding Inc.

Start price
Target price
Perf. (%)
€46.50
01.12.20
€90.00
01.12.21
-27.97%
14.12.20

Could be worthwhile Investment >10% per year
Very bad culture
No uniques
Below average Management
buy
Mccormick & Comp.

Start price
Target price
Perf. (%)
€80.99
01.12.20
€95.00
01.12.21
-4.16%
02.12.21

positive Cash Flow expected
Could be very worthwhile Investment >20% year
EBIT growth >5% per year expected
Revenue growth >5% per year expected
buy
Waste Management Inc.

Start price
Target price
Perf. (%)
€100.34
01.12.20
€105.00
01.12.21
42.22%
02.12.21

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Increased challenges to pay loans and raise capital
buy
thyssenkrupp AG

Start price
Target price
Perf. (%)
€5.90
01.12.20
-
01.12.21
93.46%
22.02.21

Business model of the past or high risk
Significant cyclical dependencies
Probably not worthwhile Investment
buy
Microsoft Corp.

Start price
Target price
Perf. (%)
€179.34
01.12.20
-
01.12.21
19.91%
12.04.21

buy
Microsoft Corp.

Start price
Target price
Perf. (%)
€179.34
01.12.20
-
01.12.21
19.91%
12.04.21

buy
Microsoft Corp.

Start price
Target price
Perf. (%)
€179.34
01.12.20
-
01.12.21
19.91%
12.04.21

buy
Microsoft Corp.

Start price
Target price
Perf. (%)
€179.34
01.12.20
-
01.12.21
19.91%
12.04.21

buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.12
01.12.20
€20.00
01.12.21
5.26%
14.12.20

Could be worthwhile Investment >10% per year
buy
Entegris Inc.

Start price
Target price
Perf. (%)
€79.00
01.12.20
€140.00
23.02.22
43.04%
06.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
positive Cash Flow expected
Small cyclical dependencies
buy
Allianz SE VNA

Start price
Target price
Perf. (%)
€200.90
01.12.20
€230.00
01.12.21
-1.67%
02.12.21

Could be worthwhile Investment >10% per year
Very capable Management
Good culture
Innovative
buy
Allianz SE VNA

Start price
Target price
Perf. (%)
€200.90
01.12.20
€230.00
01.12.21
-1.67%
02.12.21

Could be worthwhile Investment >10% per year
Very capable Management
Good culture
Innovative
buy
ShiftPixy Inc.

Start price
Target price
Perf. (%)
€202.00
30.11.20
€400.00
30.11.21
1.98%
14.12.20

Could be worthwhile Investment >10% per year
buy
Inpixon

Start price
Target price
Perf. (%)
€69.38
30.11.20
€150.00
-7.03%
14.12.20

Could be worthwhile Investment >10% per year
buy
TOP Ships Inc.

Start price
Target price
Perf. (%)
€19.60
30.11.20
€40.00
6.12%
14.12.20

Could be very worthwhile Investment >20% year
buy
Genmark Diagnostics

Start price
Target price
Perf. (%)
€11.10
30.11.20
€14.00
30.11.21
-7.21%
14.12.20

Could be worthwhile Investment >10% per year
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€13.50
30.11.20
€15.00
30.11.21
31.85%
14.12.20

Could be worthwhile Investment >10% per year
buy
Cutera Inc.

Start price
Target price
Perf. (%)
€21.00
30.11.20
€25.00
30.11.21
-15.71%
14.12.20

Could be very worthwhile Investment >20% year
buy
CHF Solutions Inc

Start price
Target price
Perf. (%)
-
30.11.20
€7.00
30.11.21
-
14.12.20

Could be very worthwhile Investment >20% year
buy
Amazon.com Inc.

Start price
Target price
Perf. (%)
€131.90
30.11.20
€150.00
30.11.21
19.41%
01.12.21

Could be worthwhile Investment >10% per year
buy
Amazon.com Inc.

Start price
Target price
Perf. (%)
€131.90
30.11.20
€150.00
30.11.21
19.41%
01.12.21

Could be worthwhile Investment >10% per year
buy
Amazon.com Inc.

Start price
Target price
Perf. (%)
€131.90
30.11.20
€150.00
30.11.21
19.41%
01.12.21

Could be worthwhile Investment >10% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.50
30.11.20
€38.00
30.11.21
18.40%
02.08.21

Could be worthwhile Investment >10% per year
Very high dividend yield expected
Fair valuation
Higher EBIT margin than peer group
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.50
30.11.20
€38.00
30.11.21
18.40%
02.08.21

Could be worthwhile Investment >10% per year
Very high dividend yield expected
Fair valuation
Higher EBIT margin than peer group
buy
Supercom

Start price
Target price
Perf. (%)
€1.46
30.11.20
€2.00
30.11.21
-42.12%
14.12.20

Could be worthwhile Investment >10% per year
Capable Management
Bad culture
Little innovation